started · updated
Brazil sees 138.5% surge in GLP-1 medication searches
Interest in GLP-1 medications in Brazil experienced significant growth between August 2025 and August 2026. Monthly searches for GLP-1 related terms rose by 138.5%, increasing from 943,000 to 2.25 million.
Data indicates a massive 775% increase in searches for specific molecules and active ingredients, which grew from 94,800 to 829,400 monthly searches. Searches for commercial brands also rose by 67.3%, reaching 1.42 million. Leading terms in August 2026 included Mounjaro with 802,900 searches, followed by tirzepatide with 610,200, and Ozivy with 203,500.
Despite this rising interest, a gap exists between consumer intent and market capture. Approximately 83% of searches are informational, while only 16% show transactional intent. Furthermore, over 80% of the analyzed searches end without a click, suggesting that consumers are primarily in a discovery phase rather than a direct purchasing phase.
Entities
Brazil · Mounjaro · Ozempic · Similarweb · Wegovy